This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Masayuki Okada: Innovator in Cancer Research
Introduction
Masayuki Okada is a prominent inventor based in Tsukuba, Japan. He is known for his significant contributions to cancer research, particularly in the development of novel therapeutic agents. His work has led to advancements in understanding and treating cancers associated with c-Kit kinase.
Latest Patents
Masayuki Okada holds a patent for a c-Kit kinase inhibitor. This invention demonstrates that a compound represented by the general formula (I) exhibits strong c-Kit kinase inhibitory activity. It has been shown to inhibit the proliferation of c-Kit kinase activated cancer cells both in vitro and in vivo. This discovery has paved the way for a novel anticancer agent that showcases c-Kit kinase inhibitory activity.
Career Highlights
Okada is affiliated with Eisai R&D Management Co., Ltd., where he continues to engage in groundbreaking research. His work has been instrumental in the development of new cancer therapies, contributing to the scientific community's understanding of kinase inhibitors.
Collaborations
Some of his notable coworkers include Tatsuo Watanabe and Yuji Yamamoto. Their collaborative efforts have further enhanced the research and development of innovative cancer treatments.
Conclusion
Masayuki Okada's contributions to cancer research through his innovative patent on c-Kit kinase inhibitors highlight his role as a key figure in the field. His work continues to inspire advancements in cancer therapy and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile